Efficacy and Safety of Apremilast in Patients With Limited Skin Involvement, Plaque Psoriasis in Special Areas, and Impaired Quality of Life
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
J Eur Acad Dermatol Venereol 2022 Oct 27;[EPub Ahead of Print], U Mrowietz, J Barker, C Conrad, D Jullien, P Gisondi, A Flower, J Reddy, M Paris, H Picard, S Jardon, M AugustinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.